The authors observed that UCA1 a lncRNA previously reported to play an oncogenic role in several malignancies, is overexpressed in the chemoresistant ovarian cancer cell line OAW42-R compared to their chemotherapy sensitive counterpart OAW42.
[Molecular Oncology]
6445212 F3GH33Q7 items 1 apa 0 default asc 1 163858 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-86a07e5ad46f3315509eb9b1cd50722d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22F3GH33Q7%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wambecke%20et%20al.%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWambecke%2C%20A.%2C%20Ahmad%2C%20M.%2C%20Morice%2C%20P.-M.%2C%20Lambert%2C%20B.%2C%20Weiswald%2C%20L.-B.%2C%20Vernon%2C%20M.%2C%20Vigneron%2C%20N.%2C%20Abeilard%2C%20E.%2C%20Brotin%2C%20E.%2C%20Figeac%2C%20M.%2C%20Gauduchon%2C%20P.%2C%20Poulain%2C%20L.%2C%20Denoyelle%2C%20C.%2C%20%26amp%3B%20Meryet-Figuiere%2C%20M.%20%28n.d.%29.%20The%20lncRNA%20%26%23x2018%3BUCA1%26%23x2019%3B%20modulates%20the%20response%20to%20chemotherapy%20of%20ovarian%20cancer%20through%20direct%20binding%20to%20miR-27a-5p%20and%20control%20of%20UBE2N%20levels.%20%3Ci%3EMolecular%20Oncology%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.13045%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.13045%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DF3GH33Q7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20lncRNA%20%5Cu2018UCA1%5Cu2019%20modulates%20the%20response%20to%20chemotherapy%20of%20ovarian%20cancer%20through%20direct%20binding%20to%20miR-27a-5p%20and%20control%20of%20UBE2N%20levels%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Wambecke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Marie%22%2C%22lastName%22%3A%22Morice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Lambert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Bastien%22%2C%22lastName%22%3A%22Weiswald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00e9gane%22%2C%22lastName%22%3A%22Vernon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Vigneron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwige%22%2C%22lastName%22%3A%22Abeilard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Brotin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Figeac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Gauduchon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Poulain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Denoyelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Meryet-Figuiere%22%7D%5D%2C%22abstractNote%22%3A%22Ovarian%20cancer%20%28OC%29%20is%20the%20leading%20cause%20of%20death%20in%20patients%20with%20gynecologic%20cancers.%20Due%20to%20late%20diagnosis%20and%20resistance%20to%20chemotherapy%2C%20the%205-year%20survival%20rate%20in%20patients%20with%20OC%20is%20below%2040%25.%20We%20observed%20that%20UCA1%20a%20lncRNA%20previously%20reported%20to%20play%20an%20oncogenic%20role%20in%20several%20malignancies%2C%20is%20overexpressed%20in%20the%20chemoresistant%20OC%20cell%20line%20OAW42-R%20compared%20to%20their%20chemotherapy%20sensitive%20counterpart%20OAW42.%20Additionally%2C%20UCA1%20overexpression%20was%20related%20to%20poor%20prognosis%20in%20two%20independent%20patient%20cohorts.%20Currently%2C%20the%20molecular%20mechanisms%20though%20which%20UCA1%20acts%20in%20OC%20are%20poorly%20understood.%20We%20demonstrated%20that%20downregulation%20of%20the%20short%20isoform%20of%20UCA1%20sensitized%20OC%20cells%20to%20cisplatin%2C%20and%20that%20UCA1%20acted%20as%20competing%20endogenous%20RNA%20to%20miR-27a-5p.%20Upon%20UCA1%20downregulation%2C%20miR-27a-5p%20downregulated%20its%20direct%20target%20UBE2N%20leading%20to%20the%20upregulation%20of%20BIM%2C%20a%20proapoptotic%20protein%20of%20the%20Bcl-2%20family.%20The%20upregulation%20of%20BIM%20is%20the%20event%20responsible%20for%20the%20sensitization%20of%20OC%20cells%20to%20cisplatin.%20In%20order%20to%20model%20response%20to%20therapy%20in%20patients%20with%20OC%2C%20we%20used%20several%20patient-derived%20organoid%20cultures%2C%20a%20model%20faithfully%20mimicking%20patient%5Cu2019s%20response%20to%20therapy.%20Inhibition%20of%20UBE2N%20sensitized%20patient-derived%20organoids%20to%20platinum%20salts.%20In%20conclusion%2C%20response%20to%20treatment%20in%20patients%20with%20OC%20is%20regulated%20by%20the%20UCA1%5C%2F%20miR-27a-5p%5C%2F%20UBE2N%20axis%2C%20where%20UBE2N%20inhibition%20could%20potentially%20represent%20a%20novel%20therapeutic%20strategy%20to%20counter%20chemoresistance%20in%20OC.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2F1878-0261.13045%22%2C%22ISSN%22%3A%221878-0261%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ffebs.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2F1878-0261.13045%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-24T16%3A57%3A14Z%22%7D%7D%5D%7D
Wambecke, A., Ahmad, M., Morice, P.-M., Lambert, B., Weiswald, L.-B., Vernon, M., Vigneron, N., Abeilard, E., Brotin, E., Figeac, M., Gauduchon, P., Poulain, L., Denoyelle, C., & Meryet-Figuiere, M. (n.d.). The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels. Molecular Oncology, n/a(n/a). https://doi.org/10.1002/1878-0261.13045 Cite